Skip to main content
. 2019 Feb 19;42(3):270–283. doi: 10.14348/molcells.2019.2364

Fig. 3. Impacts of MALAT1 and miR-197-3p on the sensitivity of lung cancer cells to chemo-therapies.

Fig. 3

(A) The MALAT1 expression was assessed after treatments with pcDNA-MALAT1 and si-MALAT1s, and miR-197-3p expression was determined after transfection of miR-197-3p mimic and miR-197-3p inhibitor. *P < 0.05 when compared with NC. (B) The effects of MALAT1 and miR-197-3p on survival rates of lung cancer cells were evaluated after treatments with cisplatin, adriamycin, gefitinib and paclitaxel. *P < 0.05 when compared with NC. NC: negative control.